Health Care & Life Sciences » Pharmaceuticals | Adamis Pharmaceuticals Corp.

Adamis Pharmaceuticals Corp.

Adamis Pharmaceuticals Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.96
Market Cap
$60.98 M
Shares Outstanding
47.64 M
Public Float
40.4 M

Profile

Address
11682 El Camino Real
San Diego California 92130
United States
Employees -
Website http://www.adamispharmaceuticals.com
Updated 07/08/2019
Adamis Pharmaceuticals Corp. is a biopharmaceutical company which is focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy. . Its activities include the combination of pharmaceuticals and biotechnology to produce medicines for patients, and physicians.

Financials

View All

David J. Marguglio
Director, Chief Business Officer & Senior VP
William C. Denby
Independent Director